Control-IQ+ is built on the existing features of Tandem Diabetes’ industry-leading Control-IQ algorithm. This is also the ...

Tandem’s Control-IQ algorithm connects the company’s own insulin pumps to Dexcom’s continuous glucose monitors. A user’s CGM transmits real-time blood sugar readings to the algorithm ...

Control-IQ+ builds on the existing features of Tandem’s industry-leading Control-IQ algorithm, which in addition to adjusting insulin every 5 minutes based on predicted glucose values ...

Representation of the closed-loop device, the Control-IQ artificial pancreas system, which uses a control algorithm developed at the University of Virginia. (Courtesy: Tandem Diabetes Care) The burden ...

Roy W. Beck, MD, Ph.D., from the JAEB Center for Health Research, and coauthors, reported that time in range (70-180 mg/dL) in the Control-IQ group increased from 57%±17% at baseline to 70%±11% ...

The FDA has expanded its clearance for Tandem Diabetes Care’s Control-IQ algorithm, which connects to an insulin pump and continuous glucose monitor to automate the process of doling out insulin ...

Positive clinical trial results for the Control-IQ algorithm from Tandem Diabetes Care presented at the American Diabetes Association meeting earlier this month positions the company to continue ...

builds on the company’s proven Control-IQ algorithm and includes enhancements to accommodate input of expanded weight and total daily insulin ranges. Control-IQ+ is expected to be available for ...

The US Food and Drug Administration (FDA) has cleared Tandem Diabetes Care’s Control-IQ+ technology, an automated insulin ...

Rushakoff, MD, MS, developed a self-adjusting subcutaneous insulin algorithm (SQIA) and embedded it in the medication ... Rushakoff reports on the glucose control results from the study at the ...